Looks like IMGN hit $20 Jan 1992 (based on hope for phase III Oncolysin that later failed, I think it was too toxic) and again in April and June 2001, biotech bubble. It also rocketed to nearly $35 in the bubble. I think this move is based on more sound fundamentals, science, real things. It's a good thing when you have to go back to 2001 to see the next resistance points. How will IMGN execs much this rally up? Will they find a way? Anyone else buy TSRX, it's on FIRE!